Kopp Family Office, LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 15, 2025), Kopp Family Office, LLC reported 27 stock positions worth $154.5 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 18.6% of the portfolio, followed by Vanguard Ftse Emerging Marke (VWO, 11.5%) and Invesco S&P 500 Equal Weight (RSP, 8.9%). Compared with Q1 2025, it sold out of 1, added to 8 and reduced 12. The biggest buy was Invesco S&P 500 Equal Weight (RSP, shares +306%) and the biggest sale an exit from iShares Russell 2000 Growth (IWO).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $154.5M (Q2 2025)
- SEC Filing
- 0000892712-25-000083 ↗ filed Jul 15, 2025
Holdings Value
Holdings 27 stocks · $154.5M
| VEA Vanguard Ftse Developed ETF | 18.60% | 504,111 | $28.7M | Reduce -12.0% |
| VWO Vanguard Ftse Emerging Marke | 11.47% | 358,490 | $17.7M | Reduce -7.5% |
| RSP Invesco S&P 500 Equal Weight | 8.87% | 75,435 | $13.7M | Add +306.0% |
| AGG iShares Core U.S. Aggregate | 7.09% | 110,380 | $10.9M | Add +1.2% |
| IJH iShares Core S&P Midcap ETF | 6.95% | 173,093 | $10.7M | Add +208.5% |
| FIVN FIVE9 Inc. | 5.12% | 298,870 | $7.9M | Reduce -10.1% |
| VCEL Vericel Corp. | 4.75% | 172,657 | $7.3M | Reduce -4.7% |
| NTNX Nutanix Inc. Class A | 4.60% | 93,071 | $7.1M | Reduce -4.6% |
| WK Workiva Inc. | 4.47% | 100,859 | $6.9M | Reduce -9.4% |
| NEO Neogenomics Inc. | 3.85% | 814,581 | $6.0M | Reduce -1.7% |
| TEAM Atlassian Corp. Class A | 3.47% | 26,393 | $5.4M | Reduce -0.2% |
| INSP Inspire Medical Systems Inc. | 3.41% | 40,614 | $5.3M | Reduce -1.0% |
| XMTR Xometry Inc. Class A | 3.01% | 137,863 | $4.7M | Add +25.1% |
| ATEC Alphatec Holdings Inc. | 2.65% | 369,355 | $4.1M | Reduce -0.3% |
| HWKN Hawkins Inc. | 2.64% | 28,658 | $4.1M | Add +92.5% |
| MANH Manhattan Associates Inc. | 2.16% | 16,941 | $3.3M | Reduce -0.2% |
| MSFT Microsoft Corp. | 2.16% | 6,724 | $3.3M | Add +1.1% |
| VRDN Viridian Therapeutics Inc. | 1.84% | 203,230 | $2.8M | Reduce -1.1% |
| VMEO Vimeo Inc. | 1.67% | 640,444 | $2.6M | Add +24.4% |
| TCMD Tactile Systems Technology I | 0.89% | 135,543 | $1.4M | Add +49.8% |
| IEFA iShares Core MSCI Eafe ETF | 0.08% | 1,400 | $117K | No change |
| ISTB iShares Core 1-5 Year Usd Bo | 0.07% | 2,173 | $106K | No change |
| IVV iShares Core S&P 500 ETF | 0.06% | 159 | $99K | No change |
| IEMG iShares Core MSCI Emerging | 0.04% | 1,150 | $69K | No change |
| IAGG iShares Intl Aggregate Bond | 0.03% | 839 | $43K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.03% | 911 | $40K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 141 | $15K | No change |
Portfolio Sells Q1 2025 → Q2 2025
| IWO iShares Russell 2000 Growth | Sold out | 0.00% | −5.32 |
| NEO Neogenomics Inc. | Reduce -1.7% | 3.85% | −1.58 |
| VEA Vanguard Ftse Developed ETF | Reduce -12.0% | 18.60% | −1.53 |
| WK Workiva Inc. | Reduce -9.4% | 4.47% | −1.37 |
| FIVN FIVE9 Inc. | Reduce -10.1% | 5.12% | −1.11 |
| INSP Inspire Medical Systems Inc. | Reduce -1.0% | 3.41% | −1.11 |
| VCEL Vericel Corp. | Reduce -4.7% | 4.75% | −0.84 |
| VWO Vanguard Ftse Emerging Marke | Reduce -7.5% | 11.47% | −0.65 |
| TEAM Atlassian Corp. Class A | Reduce -0.2% | 3.47% | −0.41 |
| NTNX Nutanix Inc. Class A | Reduce -4.6% | 4.60% | −0.11 |
| VRDN Viridian Therapeutics Inc. | Reduce -1.1% | 1.84% | −0.08 |
| ATEC Alphatec Holdings Inc. | Reduce -0.3% | 2.65% | +0.06 |
| MANH Manhattan Associates Inc. | Reduce -0.2% | 2.16% | +0.13 |
Portfolio Buys Q1 2025 → Q2 2025
| RSP Invesco S&P 500 Equal Weight | Add +306.0% | 8.87% | +6.65 |
| IJH iShares Core S&P Midcap ETF | Add +208.5% | 6.95% | +4.68 |
| HWKN Hawkins Inc. | Add +92.5% | 2.64% | +1.54 |
| XMTR Xometry Inc. Class A | Add +25.1% | 3.01% | +1.12 |
| MSFT Microsoft Corp. | Add +1.1% | 2.16% | +0.44 |
| TCMD Tactile Systems Technology I | Add +49.8% | 0.89% | +0.06 |
| VMEO Vimeo Inc. | Add +24.4% | 1.67% | −0.20 |
| AGG iShares Core U.S. Aggregate | Add +1.2% | 7.09% | −0.37 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |